Dr. Matthew Joseph Murnane, MD

Dr. Murnane practices at Albany Medical Center in Albany, New York, part of Albany Med Health System.

Dr. Murnane's NPI, 1629063979, was assigned on September 13, 2005. Dr. Murnane graduated from Albany Medical College in 1992. Dr. Murnane holds New York license 213154-1.

Dr. Murnane's primary practice is Albany Medical Center, at 43 New Scotland Avenue, Mail Code 34, Albany, NY 12208 in Albany County. The practice phone is (518) 262-2400.

Dr. Murnane's primary practice is Albany Medical Center in Albany, New York, part of Albany Med Health System. Dr. Murnane is also affiliated with Glens Falls Hospital. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Murnane to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murnane practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Murnane's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Murnane is licensed in New York.

CMS data shows 396 Medicare services from Dr. Murnane across 12 procedure codes in 2024, for 226 Medicare patients. Medicare paid $21,422 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. Murnane in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murnane's median patient age at 61, with 55% women.

In 2024, Dr. Murnane wrote 1,387 Medicare Part D claims for 183 patients. 79% of them were for generic drugs. CMS names the drug for 1,155 of them, across 35 drugs with 11 or more claims each, at $3,112,276 in total drug cost. In 2023, CMS named 1,230 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Murnane for performance year 2024, reported as part of a group. Dr. Murnane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murnane as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 24 general payments to Dr. Murnane from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Neurelis, Inc. paid the most, $426.

Dr. Murnane graduated from Albany Medical College in 1992.